menu
    • menu

    Company profile for Sangamo Therapeutics

    NEW Drugs in Dev: 16
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are committed to translating ground-breaking science into genomic therapies that transform patients’ lives. Accelerating toward the future of new genomic therapies – Since the first mapping of the human genome was completed 18 years ago, the progress of sequencing technology has accelerated exponentially. Every day we are learning more about the function and interplay of our genes, how they make us who we are, and how t...
    We are committed to translating ground-breaking science into genomic therapies that transform patients’ lives. Accelerating toward the future of new genomic therapies – Since the first mapping of the human genome was completed 18 years ago, the progress of sequencing technology has accelerated exponentially. Every day we are learning more about the function and interplay of our genes, how they make us who we are, and how they contribute to human health and disease. The therapeutic potential of the genome is being unlocked. we have become experts across a range of genomic therapies, including genome editing & regulation, gene therapy etc

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sangamo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7000 Marina Blvd, Brisbane, CA 94005
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sangamo.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sangamo Begins BLA Submission For ST-920 In Fabry Disease
    Sangamo Begins BLA Submission For ST-920 In Fabry Disease

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207689/33816/en/Sangamo-Therapeutics-Initiates-Rolling-Submission-of-BLA-to-U-S-FDA-for-ST-920-in-Fabry-Disease.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    FDA Fast-Tracks Sangamo's ST-503 for Small Fiber Neuropathy
    FDA Fast-Tracks Sangamo's ST-503 for Small Fiber Neuropathy

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197897/33816/en/Sangamo-Therapeutics-Receives-U-S-FDA-Fast-Track-Designation-for-ST-503-for-the-Treatment-of-Small-Fiber-Neuropathy.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    FDA accepts Sangamo's rolling BLA submission for Fabry
    FDA accepts Sangamo's rolling BLA submission for Fabry

    22 Nov 2025

    // PRESS RELEASE

    https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-alignment-fda-accelerated

    PRESS RELEASE
    22 Nov 2025
    Share Share
    Sangamo Pharma Highlights Q3 2025 Results
    Sangamo Pharma Highlights Q3 2025 Results

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182551/33816/en/Sangamo-Therapeutics-Reports-Recent-Business-Highlights-and-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call
    Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177881/33816/en/Sangamo-Therapeutics-Announces-Third-Quarter-2025-Earnings-Call.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Sangamo Unveils Detailed Data from STAAR Study in Fabry Disease
    Sangamo Unveils Detailed Data from STAAR Study in Fabry Disease

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144482/33816/en/Sangamo-Therapeutics-Presents-Detailed-Data-from-Registrational-STAAR-Study-in-Fabry-Disease-at-International-Congress-of-Inborn-Errors-of-Metabolism-2025.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search